Understanding heart and kidney health in African American populations
Cardiorenal Genomics for Risk Prediction in African Descent Populations
This study is looking at how high blood pressure and kidney problems affect African Americans, with the goal of finding out how their genes and environment influence how well different blood pressure medications work for them, so they can get the best treatment and live healthier lives.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10907640 on NIH RePORTER |
What this research studies
This research investigates how hypertension and chronic kidney disease affect African Americans, who experience higher rates of related health issues like stroke and heart disease. It aims to understand the genetic and environmental factors that influence how this population responds to different blood pressure medications. By analyzing data from large genomic studies, the research seeks to improve personalized treatment strategies for African Americans, ensuring they receive the most effective antihypertensive therapies. The goal is to reduce health disparities and enhance overall health outcomes in this community.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American individuals with hypertension or chronic kidney disease.
Not a fit: Patients who do not identify as African American or do not have hypertension or chronic kidney disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for hypertension and kidney disease in African Americans.
How similar studies have performed: Previous studies have shown that tailored approaches to treatment based on genetic factors can improve health outcomes, indicating potential success for this research.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Irvin, Marguerite R — University of Alabama at Birmingham
- Study coordinator: Irvin, Marguerite R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.